Literature DB >> 24338506

Cancer incidence and mortality projections up to 2020 in Catalonia by means of Bayesian models.

J Ribes1, L Esteban, R Clèries, J Galceran, R Marcos-Gragera, R Gispert, A Ameijide, M L Vilardell, J Borras, A Puigdefabregas, M Buxó, A Freitas, A Izquierdo, J M Borras.   

Abstract

PURPOSE: To predict the burden of cancer in Catalonia by 2020 assessing changes in demography and cancer risk during 2010-2020. METHODS/PATIENTS: Data were obtained from Tarragona and Girona cancer registries and Catalan mortality registry. Population age distribution was obtained from the Catalan Institute of Statistics. Predicted cases in Catalonia were estimated through autoregressive Bayesian age-period-cohort models.
RESULTS: There will be diagnosed 26,455 incident cases among men and 18,345 among women during 2020, which means an increase of 22.5 and 24.5 % comparing with the cancer incidence figures of 2010. In men, the increase of cases (22.5 %) can be partitioned in three components: 12 % due to ageing, 8 % due to increase in population size and 2 % due to cancer risk. In women, the role of each component was 9, 8 and 8 %, respectively. The increased risk is mainly expected to be observed in tobacco-related tumours among women and in colorectal and liver cancers among men. During 2010-2020 a mortality decline is expected in both sexes.
CONCLUSION: The expected increase of cancer incidence, mainly due to tobacco-related tumours in women and colorectal in men, reinforces the need to strengthen smoking prevention and the expansion of early detection of colorectal cancer in Catalonia.

Entities:  

Mesh:

Year:  2013        PMID: 24338506     DOI: 10.1007/s12094-013-1140-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  30 in total

1.  Improvement in colorectal cancer survival: a population-based study.

Authors:  Emmanuel Mitry; Anne-Marie Bouvier; Jacques Esteve; Jean Faivre
Journal:  Eur J Cancer       Date:  2005-09-01       Impact factor: 9.162

2.  Trends in mortality from leukemia in Europe: an update to 2009 and a projection to 2012.

Authors:  Paola Bertuccio; Cristina Bosetti; Matteo Malvezzi; Fabio Levi; Liliane Chatenoud; Eva Negri; Carlo La Vecchia
Journal:  Int J Cancer       Date:  2012-05-29       Impact factor: 7.396

3.  Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States.

Authors:  Hannah P Yang; William F Anderson; Philip S Rosenberg; Britton Trabert; Gretchen L Gierach; Nicolas Wentzensen; Kathleen A Cronin; Mark E Sherman
Journal:  J Clin Oncol       Date:  2013-05-06       Impact factor: 44.544

4.  Global trends in breast cancer incidence and mortality 1973-1997.

Authors:  Michelle D Althuis; Jaclyn M Dozier; William F Anderson; Susan S Devesa; Louise A Brinton
Journal:  Int J Epidemiol       Date:  2005-02-28       Impact factor: 7.196

5.  Time trends of cancer incidence and mortality in Catalonia during 1993-2007.

Authors:  R Clèries; L Esteban; J Borràs; R Marcos-Gragera; A Freitas; M Carulla; M Buxó; A Puigdefàbregas; A Izquierdo; R Gispert; J Galceran; J Ribes
Journal:  Clin Transl Oncol       Date:  2013-06-06       Impact factor: 3.405

Review 6.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006.

Authors:  Asa Klint; Laufey Tryggvadóttir; Freddie Bray; Mette Gislum; Timo Hakulinen; Hans H Storm; Gerda Engholm
Journal:  Acta Oncol       Date:  2010-06       Impact factor: 4.089

8.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

9.  The decrease in breast-cancer incidence in 2003 in the United States.

Authors:  Peter M Ravdin; Kathleen A Cronin; Nadia Howlader; Christine D Berg; Rowan T Chlebowski; Eric J Feuer; Brenda K Edwards; Donald A Berry
Journal:  N Engl J Med       Date:  2007-04-19       Impact factor: 91.245

10.  The future burden of cancer in England: incidence and numbers of new patients in 2020.

Authors:  H Møller; L Fairley; V Coupland; C Okello; M Green; D Forman; B Møller; F Bray
Journal:  Br J Cancer       Date:  2007-05-01       Impact factor: 7.640

View more
  2 in total

1.  Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.

Authors:  Miriam Potrony; Joan Anton Puig-Butillé; Paula Aguilera; Celia Badenas; Cristina Carrera; Josep Malvehy; Susana Puig
Journal:  J Am Acad Dermatol       Date:  2014-07-24       Impact factor: 11.527

2.  Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly.

Authors:  R Clèries; A Ameijide; R Marcos-Gragera; L Pareja; M Carulla; M-L Vilardell; L Esteban; M Buxó; J-A Espinàs; A Puigdefàbregas; J Ribes; A Izquierdo; J Galceran; J M Borrás
Journal:  Clin Transl Oncol       Date:  2017-10-12       Impact factor: 3.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.